Accounting & Tax
Transfer Pricing (TP): real opportunities from recent company news
kelvy reads company news and scores each event against the services a Transfer Pricing (TP) practice sells. These are real events from a sample of public companies, scored 4 or 5 out of 5.
- 5Eli Lilly and Company· Drug Manufacturers - General2 months ago
Eli Lilly to acquire psychedelic company for $360 million
Eli Lilly has agreed to acquire a psychedelic drug developer from a billionaire founder in a deal valued at $360 million. The transaction involves the sale of the entire company, with the founder receiving the full proceeds.
IP Migration / DEMPE Analysis
Lilly must document ownership and valuation of acquired psychedelic IP
Acquiring a drug developer brings heavy IP assets (patents, compounds, data) that must be valued and mapped into Lilly's existing IP structure.
- 4Eli Lilly and Company· Drug Manufacturers - General20 hours ago
InnoCare Pharma and Lilly Sign Research Collaboration and License Agreement for New Medicines
InnoCare Pharma announced on Sept. 24, 2026, a strategic research collaboration and license agreement with Lilly to develop new medicines. InnoCare Pharma is a biopharmaceutical company listed on HKEX under 09969 and SSE under 688428; financial and other terms were not included in the provided excerpt.
IP Migration / DEMPE Analysis
Both companies need to define IP ownership and development returns before research advances
The collaboration requires clear treatment of licensed IP and value created through each party’s research contributions.